Medicines in this atlas
The drugs and medicine products this atlas holds that a registry trial names or that carry a regulatory decision, with how many of each. A trial counts for a medicine when its registry record names the medicine under a name this atlas holds for it, so the table does not list every medicine used in these conditions. (page 3 of 4)
| Medicine | Type | Class | Trials | Phase 3 or 4 | Recruiting | Regulatory decisions | Sponsors |
|---|---|---|---|---|---|---|---|
| KERLEDEX | Product | 0 | 0 | 0 | 1 | 0 | |
| LEVOPHED | Product | 0 | 0 | 0 | 1 | 0 | |
| LEXXEL | Product | 0 | 0 | 0 | 1 | 0 | |
| LIPTRUZET | Product | 0 | 0 | 0 | 1 | 0 | |
| LIQUAEMIN SODIUM | Product | 0 | 0 | 0 | 2 | 0 | |
| LODOCO | Product | 0 | 0 | 0 | 1 | 0 | |
| LOPRESSOR | Product | 0 | 0 | 0 | 4 | 0 | |
| LOPRESSOR | Product | 0 | 0 | 0 | 1 | 0 | |
| LOPRESSOR | Product | 0 | 0 | 0 | 1 | 0 | |
| LOPRESSOR | Product | 0 | 0 | 0 | 1 | 0 | |
| LOPRESSOR | Product | 0 | 0 | 0 | 1 | 0 | |
| LOPRESSOR HCT | Product | 0 | 0 | 0 | 1 | 0 | |
| LOTENSIN HCT | Product | 0 | 0 | 0 | 1 | 0 | |
| LOTREL | Product | 0 | 0 | 0 | 3 | 0 | |
| LOZOL | Product | 0 | 0 | 0 | 2 | 0 | |
| MAXZIDE | Product | 0 | 0 | 0 | 2 | 0 | |
| MICARDIS | Product | 0 | 0 | 0 | 2 | 0 | |
| MICARDIS HCT | Product | 0 | 0 | 0 | 1 | 0 | |
| MICROZIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| MITIGARE | Product | 0 | 0 | 0 | 1 | 0 | |
| MODURETIC 5-50 | Product | 0 | 0 | 0 | 1 | 0 | |
| MONOPRIL-HCT | Product | 0 | 0 | 0 | 1 | 0 | |
| NEXLETOL | Product | 0 | 0 | 0 | 4 | 0 | |
| NEXLIZET | Product | 0 | 0 | 0 | 4 | 0 | |
| NEXTERONE | Product | 0 | 0 | 0 | 1 | 0 | |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | Product | 0 | 0 | 0 | 1 | 0 | |
| NORLIQVA | Product | 0 | 0 | 0 | 1 | 0 | |
| NORMOZIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| NORVASC | Product | 0 | 0 | 0 | 5 | 0 | |
| ORETIC | Product | 0 | 0 | 0 | 1 | 0 | |
| ORETICYL 25 | Product | 0 | 0 | 0 | 1 | 0 | |
| PANHEPRIN | Product | 0 | 0 | 0 | 3 | 0 | |
| PLAVIX | Product | 0 | 0 | 0 | 4 | 0 | |
| PRADAXA | Product | 0 | 0 | 0 | 1 | 0 | |
| PRALUENT | Product | 0 | 0 | 0 | 9 | 0 | |
| PRESTALIA | Product | 0 | 0 | 0 | 1 | 0 | |
| PREXXARTAN | Product | 0 | 0 | 0 | 1 | 0 | |
| PRIMACOR | Product | 0 | 0 | 0 | 1 | 0 | |
| PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER | Product | 0 | 0 | 0 | 1 | 0 | |
| PRINIVIL | Product | 0 | 0 | 0 | 4 | 0 | |
| PRINZIDE | Product | 0 | 0 | 0 | 2 | 0 | |
| PROCARDIA | Product | 0 | 0 | 0 | 3 | 0 | |
| PROCARDIA XL | Product | 0 | 0 | 0 | 1 | 0 | |
| PROPRANOLOL HYDROCHLORIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| QBRELIS | Product | 0 | 0 | 0 | 1 | 0 | |
| QTERN | Product | 0 | 0 | 0 | 2 | 0 | |
| QTERNMET XR | Product | 0 | 0 | 0 | 1 | 0 | |
| RAVOCAINE AND NOVOCAIN W/ LEVOPHED | Product | 0 | 0 | 0 | 1 | 0 | |
| REGROTON | Product | 0 | 0 | 0 | 1 | 0 | |
| ROSZET | Product | 0 | 0 | 0 | 2 | 0 | |
| RYBELSUS | Product | 0 | 0 | 0 | 3 | 0 | |
| RYBELSUS | Product | 0 | 0 | 0 | 1 | 0 | |
| Sacubitril/valsartan (Entresto) | Product | 0 | 0 | 0 | 4 | 0 | |
| SAVAYSA | Product | 0 | 0 | 0 | 5 | 0 | |
| SDAMLO | Product | 0 | 0 | 0 | 1 | 0 | |
| SER-AP-ES | Product | 0 | 0 | 0 | 1 | 0 | |
| SERPASIL-ESIDRIX #1 | Product | 0 | 0 | 0 | 1 | 0 | |
| SIMVASTATIN | Product | 0 | 0 | 0 | 1 | 0 | |
| SYNJARDY | Product | 0 | 0 | 0 | 6 | 0 | |
| SYNJARDY XR | Product | 0 | 0 | 0 | 5 | 0 | |
| TARKA | Product | 0 | 0 | 0 | 1 | 0 | |
| TECZEM | Product | 0 | 0 | 0 | 1 | 0 | |
| TEKAMLO | Product | 0 | 0 | 0 | 1 | 0 | |
| TEKTURNA HCT | Product | 0 | 0 | 0 | 2 | 0 | |
| TENORETIC 100 | Product | 0 | 0 | 0 | 1 | 0 | |
| TENORMIN | Product | 0 | 0 | 0 | 4 | 0 | |
| TENORMIN | Product | 0 | 0 | 0 | 1 | 0 | |
| TEVETEN HCT | Product | 0 | 0 | 0 | 1 | 0 | |
| THALITONE | Product | 0 | 0 | 0 | 1 | 0 | |
| TIAZAC | Product | 0 | 0 | 0 | 2 | 0 | |
| TIMOLIDE 10-25 | Product | 0 | 0 | 0 | 3 | 0 | |
| TNKASE | Product | 0 | 0 | 0 | 2 | 0 | |
| TOPROL-XL | Product | 0 | 0 | 0 | 4 | 0 | |
| TRIBENZOR | Product | 0 | 0 | 0 | 1 | 0 | |
| TRIJARDY XR | Product | 0 | 0 | 0 | 2 | 0 | |
| TWYNSTA | Product | 0 | 0 | 0 | 1 | 0 | |
| UNIRETIC | Product | 0 | 0 | 0 | 1 | 0 | |
| VALTURNA | Product | 0 | 0 | 0 | 1 | 0 | |
| VASCEPA | Product | 0 | 0 | 0 | 2 | 0 | |
| VASERETIC | Product | 0 | 0 | 0 | 2 | 0 | |
| VASOTEC | Product | 0 | 0 | 0 | 6 | 0 | |
| VERAPAMIL HYDROCHLORIDE | Product | 0 | 0 | 0 | 1 | 0 | |
| VERELAN | Product | 0 | 0 | 0 | 1 | 0 | |
| VERELAN PM | Product | 0 | 0 | 0 | 1 | 0 | |
| VOSTALLY | Product | 0 | 0 | 0 | 1 | 0 | |
| VYNDAMAX | Product | 0 | 0 | 0 | 1 | 0 | |
| VYNDAQEL | Product | 0 | 0 | 0 | 1 | 0 | |
| VYTORIN | Product | 0 | 0 | 0 | 5 | 0 | |
| WEGOVY | Product | 0 | 0 | 0 | 1 | 0 | |
| WIDAPLIK | Product | 0 | 0 | 0 | 1 | 0 | |
| XARELTO | Product | 0 | 0 | 0 | 7 | 0 | |
| XARELTO | Product | 0 | 0 | 0 | 1 | 0 | |
| XIGDUO XR | Product | 0 | 0 | 0 | 7 | 0 | |
| YULZETY | Product | 0 | 0 | 0 | 1 | 0 | |
| ZEBETA | Product | 0 | 0 | 0 | 1 | 0 | |
| ZEPBOUND (AUTOINJECTOR) | Product | 0 | 0 | 0 | 4 | 0 | |
| ZESTORETIC | Product | 0 | 0 | 0 | 2 | 0 | |
| ZESTRIL | Product | 0 | 0 | 0 | 5 | 0 |
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 3
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 5
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 3
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 9
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 3
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
RAVOCAINE AND NOVOCAIN W/ LEVOPHED
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 3
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
Sacubitril/valsartan (Entresto)
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 5
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 6
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 5
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 3
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 6
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 5
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 7
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 7
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 1
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 4
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 2
- Sponsors
- 0
-
- Type
- Product
- Class
- Trials
- 0
- Phase 3 or 4
- 0
- Recruiting
- 0
- Regulatory decisions
- 5
- Sponsors
- 0